RENAL CELL CARCINOMA:

IMMEDIATE SURGERY OR SURGERY AFTER SUNITINIB IN TREATING PATIENTS WITH METASTATIC KIDNEY CANCER.

Trial ID: EORTC-30073/NCT01099423

Coordination: EORTC

Trial Design: Phase III

Patient Population: Metastatic clear cell renal cell carcinoma with a resectable asymptomatic in situ primary.

Sample size & primary endpoint: n=458, progression-free survival